Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
Diabetes Australia
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
Hoffmann-La Roche
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
National Health and Medical Research Council, Australia
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Completed
Baker Heart Research Institute
N/A
2002-10-01
The purpose of this project is to determine whether glucose metabolism can be improved by
administering a substance (nitric oxide donor) normally released by muscles during exercise.
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
Completed
UCB Pharma
Phase 3
2006-01-01
The main purpose of this research study is to determine whether the drug Levetiracetam
(Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™)
has been approved for the treatment of seizures by the U.S. Federal Food and Drug
Administration (FDA) and is available by prescription. Levetiracetam has not been approved
by the FDA for the treatment of panic disorder.
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
Completed
University of Cincinnati
Phase 3
2006-01-01
The main purpose of this research study is to determine whether the drug Levetiracetam
(Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™)
has been approved for the treatment of seizures by the U.S. Federal Food and Drug
Administration (FDA) and is available by prescription. Levetiracetam has not been approved
by the FDA for the treatment of panic disorder.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
